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ABSTRACT 
NTM infections are an emerging global public health problem, especially in developing world. NTM and MTBC were proven to be responsible for 
various lungs, soft and skin tissues, and disseminated infections. Microscopy of AFB is rapid; however it does not discriminate between MTBC 
and NTM. Biochemical tests are time taking and interpretation of results may be difficult. The  GenoType®  Mycobacterium  CM/AS  assay  is 
reliable and rapid detection method in species of mycobacteria, which can  give  patients  with the onset  of  early targeted therapy. In present 
study, 189 patients detect by sputum sampling from total 3320 patients. 
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Infection of Non tuberculosis Mycobacteria (NTM) is regard 
as serious health concern around the world1-4. 
Mycobacterium genus belongs to Mycobacteriaceae family 
includes gram-positive bacteria and one of many mycolic 
acid involving genera among the Actinomycetes order. In the 
past, they were reported as mycobacterium rather than 
tuberculosis, atypical mycobacteria, but later, known as 
NTM5-8. Typical mycobacteria are spreading by cough from 
infected person to healthy individual in the near 
surrounding, which usually affect the lungs; NTM which is 
readily isolated from water and soil among the group of 
diverse species of Mycobacteria present in the atmosphere. 
Except Mycobacterium tuberculosis complex (MTBC) and 
Mycobacterium leprae, NTM incorporate all other species of 
mycobacteria. NTM are divided into two types of species one 
is Rapid growing mycobacteria (RGM) and other is Slow 
growing mycobacteria (SGM). Occurrence of NTM has been 
reported in human respiratory and non-respiratory diseases. 
A continuous global rise in NTM incidence is a big concern 
for physicians and microbiologists. Earlier in various 
developing countries, the   higher   occurrence of 
tuberculosis has   surpassed   the identification of NTM 
associated infections9-12. Most of these are present mainly in 
the form of saprophytes in the natural surrounding and have 
been identified as an etiological agent in human diseases. 
Now days this trend is changing with great pace. Higher 
reporting of NTM related pulmonary disease leads to 
international attention13-15. As of, 2014 estimated incidence 
of respiratory disease was 33–65 per 100,000 due to NTM16. 
In present study, we detected non-tuberculosis mycobacteria 
by sputum sampling from patients. 
MATERIALS AND METHODS 
Study Design and Study Setting 
This study designed as a prospective hospital based study in 
Northern India at department of Microbiology, Sanjay 
Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 
UP India. 
Selection of Subjects 
Patients were suspected of tuberculosis cases and fulfilling 
the criteria for the inclusion of in and out patients in 
different wards of SGPGIMS, Lucknow was included in the 
study. All samples are received in the laboratory from all 
over the U.P, India. Study Performa was include history of 
current and past illness of tuberculosis, history of anti-
tubercular treatment past and history related to other 
disease. 
METHODOLOGY 
Collection of Specimens and Laboratory Procedures 
Pulmonary specimens were collected at various wards of 
SGPGIMS and send to the Mycobacteriology laboratory, 
SGPGIMS, within an hour’s of collection of specimens. All the 
samples were collected by resident In-charge on duty as a 
part of its diagnosis. Samples were confirmed for leakage 
and outside of tubes were wiped with spirit swab before 
processing. All the specimens were processed on the day of 
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collection. Samples were processed in laminar flow hood 
with Class II Biological Safety level. There have no separate 
samples were collected for the research. Data of clinical and 
epidemiological was collected from patients with hospital 
information system and patient history case sheets. 
Labeling of Samples  
– On the specimen container  
– On the field data collection form                     
– On the log book  
– Subject’s name  
– Subject’s unique identification number  
Storage of Specimens  
Store specimens at 4 °C before and during transportation 
within 48 hours  
Store specimens at -70 °C beyond 48 hours. 
Ziehl Neelsen Staining Procedure 
The recommended method for staining mycobacteria is the 
Ziehl Neelsen but less sensitive. ZN is described as hot 
method of staining for mycobacteria, used to identify the 
acid fact organisms of mycobacteria. It is more sensible to 
make use of a weaker decolorizing agent for staining NTM as 
they may be more sensitive to the AFB decolonization 
procedure. Finally smear staining was done by standard ZN 
Method for AFB (Figure 1): 
 
Figure 1 AFB in culture smear (ZN staining) 
Mycobacterial Culture Processing 
Process of samples were centrifuged and were directly 
inoculated using syringe into the BacT/Alert MP vials of the 
BacT/Alert 3D system (bioMerieux, France) which 
restraining modified Middlebrook 7H9 with supplement of 
an antibiotic containing  (azlocillin [0.0034%, wt/vol] , 
vancomycin [0.0005%, wt/vol]), polymyxin B [10,000 U], 
nalidixic acid [0.04%, wt/vol], trimethoprim [0.00105%, 
wt/vol] and amphotericin B [0.018%, wt/vol] (Figure ).  And 
also inoculate processed samples (0.2 ml) in 3% LJ medium 
and cultured for eight weeks in an incubator at 35-37℃ 
under 5-10% CO2 (Figure 7). BacT/Alert 3D vials was 
continuous observed  by the BacT/Alert 3D system. 
BacT/alert system shows positive vials for the existence of 
acid fast bacilli (AFB) were subjected to smear microscopy 
(Figure 8). No growth after 42 days of incubation was 
treated as negative growth for mycobacteria. Then positive 
culture was further identified by phenotypic as well as 
genotypic.  
Cultures with positive growth on the BacT/ALERT 3D and 
presence of AFB by ZN stain were screened with biochemical 
tests which included niacin production, catalase activity at 
68 C at pH 7, and were tested with a rapid TB antigen assay 
(SD-Bioline Ag MPT64 Rapid TM assay; Standard 
Diagnostics, Kyonggi-do, Korea) which identifies antigens 
specific to MTBC. Isolates confirmed as MTB then went 
through a drug susceptibility test with the polymerase chain 
reaction based Genotype MTBDR plus test (Hain Lifescience, 
Nehren, Germany). Cultures with positive growth on 
BacT/ALERT 3D and the presence of AFB by ZN stain but 
that were negative for MTBC using the SD-Bioline assay were 
further identified for the species level. 
Species Identification of NTM 
Characterization of species was carried out with the reverse 
hybridization-based line probe assay as per the 
manufacturer’s instructions. 
RESULTS  
In this study, 3320 sputum specimens, suspected cases of 
tuberculosis were included for the presence of 
mycobacterium species. Out of 3320 samples, Smear 
microscopy test showed 512 (15.4 %) positive for AFB by ZN 
staining. Further, 652 (19.6%) cases were BacT/ALERT® MP 
culture positive.     
Culture positive isolates were subjected for species 
identification with the help of several phenotypic and 
genotypic methods, which results in 189 (29%) as NTM and 
463 (71%) as MTBC isolates.         
Clinical Symptoms of Pulmonary NTM Patients 
Respiratory symptoms are most frequent among pulmonary 
patients including cough dyspnoea, hemoptysis, fever, 
weight loss, fatigue .Out of 189 sputum NTM positive cases 
have 122 (64.5%) cough, hemoptysis 27 (14%), dyspnoea 95 
(50%), Fatigue 89 (47%) , 55 weight loss (50%) and fever 57 
(30%) Table 1.  
Table 1: Clinical symptoms of pulmonary infected ntm 
patients 
Symptoms N= 189%  
Cough 122 (64.5%) 
Dyspnoea 95 (50%) 
Fatigue 89 (47%) 
Fever 57 (30%) 
Hemoptysis 27 (14 %) 
Weight loss  55 (26%) 
 
NTM Species in Sputum Isolates  
M. abscessus 59, M. fortuitum 38, M. intracellular 25, M. avium 
16, M. chelonae 14, M.simiae 9, M.interjectum 9, M.gordonae 6, 
M.kanasii 5 M.szulgai 4 , M.malmoense 2, M.intermedium 1, M. 
scrofulaceum 1 species were reported from respiratory 
samples. Whereas M. abscessus and M. fortuitum were 
frequently isolated from Sputum specimen from pulmonary 
infections  
Additionally, we observed in our study that 42 (22%) 
patients were smokers, while 189 (78%) were non-smokers. 
A total of 57 (30%) out of 189 isolates were TB retreatment 
patients, infected with NTM. In our study, 125 (66%) NTM 
infected patients were married whereas 64    (33.8%) who 
were not presently married. 
DISCUSSION AND CONCLUSION 
NTM infections are an emerging global public health 
problem, especially in developing world. NTM and MTBC 
were proven to be responsible for various lungs, soft and 
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skin tissues, and disseminated infections. Microscopy of AFB 
is rapid; however it does not discriminate between MTBC 
and NTM. Biochemical tests are time taking and 
interpretation of results may be difficult. The  GenoType®  
Mycobacterium  CM/AS  assay  is reliable and rapid detection 
method in species of mycobacteria, which can  give  patients  
with the onset  of  early targeted therapy. We have reported 
in this study, the prevalence of NTM and its species diversity 
addresses in respiratory and non- respiratory samples 
gained from population of Northern India.  
In our study, most recurrent NTM species reported in 
sputum specimens among pulmonary disease was M. 
abscessus, this suggests its high prevalence could be the 
result of its abundance in this region and its feature of drug 
resistance and pathogenicity leads to its persistence in this 
area. 
In most part of India records of NTM was reported very less. 
The reason for this may be lack of awareness in the 
unorganized laboratory structure, limited funds, other 
burden of disease, in the hospital as well in rural settings 
among clinicians  and microbiologist especially. 
The higher occurrence of NTM and its species diversity 
suggests the urgent need and exact characterization 
including antibiotic susceptibility connected with NTM 
required for appropriate management and treatment of 
patients. 
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